Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS5626-TPS5626
Author(s):  
Alicia Hurtado ◽  
Jesús García-Donas ◽  
Laia Garrigos ◽  
Nuria Laínez ◽  
Andres Redondo ◽  
...  
2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS5612-TPS5612
Author(s):  
Jf. Rodriguez-Moreno ◽  
Jesús García-Donas ◽  
Laia Garrigos ◽  
Nuria Laínez ◽  
Ana Santaballa ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. TPS2598-TPS2598
Author(s):  
Laia Garrigos ◽  
Ana Santaballa ◽  
Alicia Hurtado ◽  
Juan Francisco Rodriguez-Moreno ◽  
Ricardo Sanchez-escribano ◽  
...  

2018 ◽  
Author(s):  
Giuseppe Lombardi ◽  
Gian Luca De Salvo ◽  
Alba Ariela Brandes ◽  
Marica Eoli ◽  
Roberta Rudà ◽  
...  

2018 ◽  
Vol 20 (suppl_3) ◽  
pp. iii219-iii219
Author(s):  
G Lombardi ◽  
G de Salvo ◽  
R Rudà ◽  
E Franceschi ◽  
M Eoli ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S1251-S1252
Author(s):  
Gøran Andersen ◽  
Chun-Mei Zhao ◽  
Xing Cai ◽  
Hanne-Line Rabben ◽  
James G. Fox ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document